Matthew Pauls
CHIEF EXECUTIVE OFFICER at Savara Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Savara Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Savara Inc. June 4, 202698.2%
-
Pelthos Therapeutics Inc. December 17, 202599.9%
-
Savara Inc. June 5, 202598.8%
-
Savara Inc. June 6, 202498.8%
-
Savara Inc. June 8, 202399.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −786 | $21.00 | $16,506 |
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −692 | $26.00 | $17,992 |
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −94 | $27.36 | $2,572 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −415 | $20.52 | $8,516 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −371 | $21.36 | $7,925 |
| Dec 16, 2025 | Savara Inc. | Gift | −128,995 | — | — |
| Dec 14, 2025 | Savara Inc. | Shares withheld for tax | −195,705 | $6.92 | $1,354,279 |
| Dec 10, 2025 | Savara Inc. | Gift | −23,629 | — | — |
| Dec 10, 2025 | Pelthos Therapeutics Inc. | Gift | −9,542 | — | — |
| Oct 2, 2025 | Pelthos Therapeutics Inc. | Option exercise | +2,123 | — | — |
| Jul 2, 2025 | Pelthos Therapeutics Inc. | Option exercise | +8,493 | — | — |
| Dec 16, 2024 | Savara Inc. | Open-market sale | −54,702 | $3.31 | $181,064 |
| Dec 13, 2024 | Savara Inc. | Shares withheld for tax | −92,593 | $3.21 | $297,224 |
| Dec 12, 2024 | Savara Inc. | Grant or award | +400,000 | — | — |
| Dec 28, 2023 | Savara Inc. | Open-market sale | −84,000 | $4.71 | $395,640 |
Questions about Matthew Pauls
What boards is Matthew Pauls on?
Matthew Pauls sits on the boards of Palvella Therapeutics Inc., Pelthos Therapeutics Inc. and Savara Inc.
What company is Matthew Pauls the CEO of?
Matthew Pauls is CHIEF EXECUTIVE OFFICER of Savara Inc.
How long has Matthew Pauls served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.